261 related articles for article (PubMed ID: 22827554)
1. Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4.
Labouesse MA; Stadlbauer U; Weber E; Arnold M; Langhans W; Pacheco-López G
J Neuroendocrinol; 2012 Dec; 24(12):1505-16. PubMed ID: 22827554
[TBL] [Abstract][Full Text] [Related]
2. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat.
Arnold M; Mura A; Langhans W; Geary N
J Neurosci; 2006 Oct; 26(43):11052-60. PubMed ID: 17065447
[TBL] [Abstract][Full Text] [Related]
3. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
5. Vagal afferents mediate the feeding response to mercaptoacetate but not to the beta (3) adrenergic receptor agonist CL 316,243.
Brandt K; Arnold M; Geary N; Langhans W; Leonhardt M
Neurosci Lett; 2007 Jan; 411(2):104-7. PubMed ID: 17112664
[TBL] [Abstract][Full Text] [Related]
6. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
7. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
8. Subdiaphragmatic vagal deafferentation fails to block the anorectic effect of hydroxycitrate.
Leonhardt M; Hrupka BJ; Langhans W
Physiol Behav; 2004 Sep; 82(2-3):263-8. PubMed ID: 15276787
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy.
Ripken D; van der Wielen N; van der Meulen J; Schuurman T; Witkamp RF; Hendriks HF; Koopmans SJ
Physiol Behav; 2015 Feb; 139():167-76. PubMed ID: 25449395
[TBL] [Abstract][Full Text] [Related]
10. Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats.
Schwartz GJ; Plata-Salamán CR; Langhans W
Am J Physiol; 1997 Sep; 273(3 Pt 2):R1193-8. PubMed ID: 9321903
[TBL] [Abstract][Full Text] [Related]
11. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
Rüttimann EB; Arnold M; Hillebrand JJ; Geary N; Langhans W
Endocrinology; 2009 Mar; 150(3):1174-81. PubMed ID: 18948395
[TBL] [Abstract][Full Text] [Related]
12. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
[TBL] [Abstract][Full Text] [Related]
13. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.
Koda S; Date Y; Murakami N; Shimbara T; Hanada T; Toshinai K; Niijima A; Furuya M; Inomata N; Osuye K; Nakazato M
Endocrinology; 2005 May; 146(5):2369-75. PubMed ID: 15718279
[TBL] [Abstract][Full Text] [Related]
14. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.
Baumgartner I; Pacheco-López G; Rüttimann EB; Arnold M; Asarian L; Langhans W; Geary N; Hillebrand JJ
J Neuroendocrinol; 2010 Jun; 22(6):557-63. PubMed ID: 20298455
[TBL] [Abstract][Full Text] [Related]
15. Peripheral glucagon-like peptide-1 (GLP-1) and satiation.
Punjabi M; Arnold M; Geary N; Langhans W; Pacheco-López G
Physiol Behav; 2011 Nov; 105(1):71-6. PubMed ID: 21371486
[TBL] [Abstract][Full Text] [Related]
16. The role of the vagus nerve in mediating the long-term anorectic effects of leptin.
Sachot C; Rummel C; Bristow AF; Luheshi GN
J Neuroendocrinol; 2007 Apr; 19(4):250-61. PubMed ID: 17355316
[TBL] [Abstract][Full Text] [Related]
17. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
[TBL] [Abstract][Full Text] [Related]
19. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor.
Washington MC; Raboin SJ; Thompson W; Larsen CJ; Sayegh AI
Brain Res; 2010 Jul; 1344():124-33. PubMed ID: 20452329
[TBL] [Abstract][Full Text] [Related]
20. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
